Potentiation of 5-fluorouracil cytotoxicity by combining hyperthermia and dipyridamole in vitro
- PMID: 2817823
Potentiation of 5-fluorouracil cytotoxicity by combining hyperthermia and dipyridamole in vitro
Abstract
Evidence was obtained for the augmentation of cytotoxic effects of 5-fluorouracil (5-FU) when hyperthermia and dipyridamole (DP) were combined in vitro. Nontoxic levels of DP enhanced the combined cytotoxicity of 5-FU and heat against HeLa and B16 melanoma cells, and the 50% effective concentration of 5-FU decreased 7.3 fold for HeLa cells and 3.0 fold for B16 melanoma cells, when exposed to heat plus DP. This combined effect did not depend on intracellular increases in the concentrations of 5-FU. Thus hyperthermia together with DP seems to improve the sensitivity of tumor cells to 5-FU. As the sensitivity of colorectal cancer tissue to drugs is low, 5-FU plus hyperthermia and DP shows promise for the treatment of such patients.
Similar articles
-
Dipyridamole augments the antitumor effects of fluorinated pyrimidines.Anticancer Res. 1992 Jan-Feb;12(1):119-21. Anticancer Res. 1992. PMID: 1567156
-
Potentiation of adriamycin cytotoxicity by dipyridamole against HeLa cells in vitro and sarcoma 180 cells in vivo.Cancer Res. 1988 Mar 1;48(5):1208-12. Cancer Res. 1988. PMID: 3342401
-
Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor.Anticancer Drug Des. 1993 Aug;8(4):289-97. Anticancer Drug Des. 1993. PMID: 8240657
-
Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experience.Semin Oncol. 1992 Apr;19(2 Suppl 3):56-65. Semin Oncol. 1992. PMID: 1557658 Review.
-
Modulation of the activity of cancer chemotherapeutic agents by dipyridamole.Cancer Treat Res. 1991;58:19-44, 155-6. doi: 10.1007/978-1-4615-3876-9_2. Cancer Treat Res. 1991. PMID: 1683784 Review. No abstract available.
Cited by
-
5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole.Cancer Chemother Pharmacol. 1992;29(4):257-60. doi: 10.1007/BF00685941. Cancer Chemother Pharmacol. 1992. PMID: 1537070
-
Effect of gastrectomy on the pharmacokinetics of tegafur, uracil, and 5-fluorouracil after oral administration of a 1:4 tegafur and uracil combination.Cancer Chemother Pharmacol. 1994;33(6):445-9. doi: 10.1007/BF00686498. Cancer Chemother Pharmacol. 1994. PMID: 8137453
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials